PubRank

K S Fuson

Author PubWeight™ 13.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem 2001 4.45
2 Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 1994 1.92
3 Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity. J Neurochem 1996 1.70
4 Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-beta neurotoxicity. J Neurochem 1993 1.33
5 Fibroblast growth factor-8 protects cultured rat hippocampal neurons from oxidative insult. Brain Res 1999 0.83
6 Characterization of 8-epiprostaglandin F2alpha as a marker of amyloid beta-peptide-induced oxidative damage. J Neurochem 1999 0.78
7 Induction of sulfated glycoprotein-2 (clusterin) and glial fibrillary acidic protein (GFAP) RNA expression following transient global ischemia is differentially attenuated by LY231617. Brain Res Mol Brain Res 1996 0.77
8 Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. Neurosci Lett 1999 0.77
9 Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol 1993 0.76
10 Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490). J Neural Transm (Vienna) 1996 0.75